You May Also Be Interested In:
GMP, DMF available;
API and formulation
This product is a broad-spectrum antibiotic, suitable for mixed infections caused by multiple pathogens and aerobians/anaerobians, and for early treatment prior to the ascertainment of pathogenic bacteria. This product is suitable for the following infections caused by sensitive bacteria:
Lower respiratory tract infection
Genitourinary tract infection
Bone and joint infection
Skin and soft tissue infection
This product is suitable for mixed infections caused by sensitive aerobians/anaerobians mainly related to the contamination of bacterial strains of stool, vagina, skin and mouth. Bacteroides fragilis are the most common anaerobians in these mixed infections, and they are usually resistant to antibiotics like aminoglycosides, cephalosporins and penicillins but sensitive to this product.
It is proved that this product has very powerful antibiotic activity against some bacteria resistant to cephalosporins including aerobic and anaerobic gram positive and negative bacteria. The cephem antibiotics resisted by these bacteria include cefazolin, cefoperazone, cafalotin, cefoxitin, cefotaxim, moxalactam, cefamandole, ceftazidime and ceftriaxone. Similarly, this product is also effective to infections caused by bacteria resistant to aminoglycoside antibiotics (gentamycin, amikacin and tenebrimycin) and/or penicillins (ampicillin, carbenicillin, penicillin, ticarcillin, piperacillin, azlocillin, mezlocillin) .
This product is not suitable for treatment of meningitis.